Detalhe da pesquisa
1.
GM-CSF elicits antibodies to tumor-associated proteins when used as a prostate cancer vaccine adjuvant.
Cancer Immunol Immunother
; 71(9): 2267-2275, 2022 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-35133464
2.
Targeted Radiation and Immune Therapies-Advances and Opportunities for the Treatment of Prostate Cancer.
Pharmaceutics
; 15(1)2023 Jan 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36678880
3.
Role of B cells as antigen presenting cells.
Front Immunol
; 13: 954936, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36159874
4.
Antitumor efficacy of 90Y-NM600 targeted radionuclide therapy and PD-1 blockade is limited by regulatory T cells in murine prostate tumors.
J Immunother Cancer
; 10(8)2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-36002185
5.
Antibody profiling of patients with prostate cancer reveals differences in antibody signatures among disease stages.
J Immunother Cancer
; 8(2)2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33335027
6.
Ordered patterning of the sensory system is susceptible to stochastic features of gene expression.
Elife
; 92020 02 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-32101167
7.
Treatment Combinations with DNA Vaccines for the Treatment of Metastatic Castration-Resistant Prostate Cancer (mCRPC).
Cancers (Basel)
; 12(10)2020 Sep 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-33008010